Boehringer Ingelheim Launches NexGard COMBO - Broad-spectrum Parasiticide Offering Unparalleled Parasite Protection For Cats
3 years ago 
1480 views
Boehringer Ingelheim Animal Health has extended its popular NexGard parasiticide range with the launch of NexGard COMBO spot-on, the first and only broad-spectrum parasiticide to treat cats for these key parasites: fleas, ticks, ear mites, roundworms and tapeworms.
NexGard COMBO is an exciting, new isoxazoline-based endectocide, specifically designed for cats and consists of a trilogy of active ingredients - esafoxolaner, eprinomectin and praziquantel.
This ground-breaking, broad-spectrum parasiticide provides one month’s protection against fleas, killing them within 24 hours, before they lay eggs, and can be used as part of a flea allergy dermatitis (FAD) treatment strategy. It kills Ixodes ricinus, the most common tick on cats, within 48 hours and protection lasts for five weeks. As well as treating the roundworms, Toxocara cati and Toxascaris leonina, hookworms and tapeworms, NexGard COMBO provides 97.2 to 99.9% efficacy following just one treatment against ear mites1.
Administered as a spot-on with a systemic mode of action, NexGard COMBO is easy to administer via its unique applicator.
NexGard COMBO can be used in kittens from just eight weeks of age and 0.8 kg in weight, making it suitable for most kittens at first vaccination. It is available in two pack sizes: small, for kittens weighing 0.8 - 2.5kg and large, for adult cats weighing 2.5 - 7.5kg. For cats weighing 7.5kg or over an appropriate combination of applicators should be used.
Jackie Sterratt, senior brand manager at Boehringer Ingelheim, comments: “We’re excited to add to the successful NexGard range and to help vets treat more cats. We know only one in two cats is treated for fleas2 and cats are only wormed on average three times per year3 despite all cats being at risk of fleas and most cats requiring monthly roundworming treatment2, 3, so there is a big opportunity to increase treatment rates and compliance. As the only product on the market to treat fleas, ticks, ear mites, roundworms and tapeworms, NexGard COMBO offers a simple solution for cats at risk of multiple parasites."
To support the launch of NexGard COMBO, Boehringer Ingelheim has introduced an eye-catching and informative NexGard COMBO marketing package which includes a kitten support pack, client leaflets, dispensing envelope and parasite risk checker.
For further information on NexGard COMBO vets can contact their local Boehringer Ingelheim territory manager or phone 01344 746957 (UK) or 01 291 3985 (Ireland).
References
- Tielemans E, Prullage J, Tomoko O, et al. Efficacy of a novel topical combination of esafoxolaner, eprinomectin and praziquantel against ear mite (Otodectes cynotis) infections in cats. Parasite 2021:28.
- Cooper A-R. et al. (2020). Fleas infesting cats and dogs in Great Britain; spatial distribution of infestation risk and its relation to treatment. Medical and Veterinary Entomology. Doi:10.1111/mve12462.
- McNamara J. et al. (2018). Survey of European pet owners quantifying endoparasitic infection risk and implications for deworming recommendation. Parasite Vectors;11:571.
More from Boehringer Ingelheim
- Boehringer Ingelheim receives FDA approval for SENVELGO® (velagliflozin oral solution): the first oral liquid medication for diabetes in cats
- Boehringer Ingelheim Animal Health launches new ProZinc webinar and toolkit
- NexGard Spectra ‘Yum and Done’ competition winner announced
- Boehringer Ingelheim launches Parassess - a “first-of-its-kind”, online, personalised dog parasite risk checker
- ABCD & Boehringer Ingelheim invite applications for the 2022 Young Scientist Award
3 days ago 